The Allstate Corporation (ALL) has been a top performer among
health insurance stocks. The strong Q4 2024 earnings, solid revenue growth, and strategic moves have been key highlights. Notably, the corporation reported strong 2024 financial results with increased premium and investment income. Its Q4 earnings surpassed estimates, with an EPS of $7.67. Various notable firms, including
Groesbeck Investment Management Corp NJ and Strategic Financial Concepts LLC, increased their stakes in ALL. Simultaneously, firms such as
Tobam and abrdn plc sold their shares. Allstate took a calculated financial decision by selling its Group Health arm to
Nationwide for $1.25 billion. Additionally, the company's stock value has been projected optimistically with BMO maintaining an outperform rating with a $222 target, and CFRA raising ALL's rating to a 'Strong Buy' with a $230 target. However, Allstate expects $1.1 billion in losses from
Los Angeles Fires.
The Allstate Corporation ALL News Analytics from Thu, 29 Aug 2024 07:00:00 GMT to Sat, 08 Feb 2025 20:57:00 GMT -
Rating 8
- Innovation 7
- Information 9
- Rumor 4
